ALAlphabet Inc.
Institutional investor · Portfolio as of Q3 2020
Top Holdings24 positions
JD.COM INC | 13.6M | $1.1B | 49.4% | $24.72 | +211.59% | 5 qtrssince 2019-Q3 | Unchanged 0 |
LYFT INCA | 12.8M | $353.4M | 16.6% | $40.84 | -32.54% | 5 qtrssince 2019-Q3 | Unchanged 0 |
DEXCOM INC | 805,681 | $332.1M | 15.6% | $52.30 | +97.04% | 5 qtrssince 2019-Q3 | Unchanged 0 |
ARCUS BIOSCIENCES INC | 5M | $86.6M | 4.1% | $9.10 | +88.35% | 5 qtrssince 2019-Q3 | Unchanged 0 |
RELAY THERAPEUTICS INC | 1.8M | $76.7M | 3.6% | $42.59 | 0.00% | 1 qtr | New 83 |
LEMONADE INC | 824,743 | $41M | 1.9% | $49.72 | 0.00% | 1 qtr | New 67 |
Slack Technologies Inc. | 1.3M | $34.9M | 1.6% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
RAPT THERAPEUTICS INC | 836,059 | $26.9M | 1.3% | — | — | 4 qtrssince 2019-Q4 | Unchanged 0 |
| 3.3M | $22.7M | 1.1% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 | |
BEAM THERAPEUTICS INC | 663,691 | $16.3M | 0.8% | $18.00 | +36.78% | 3 qtrssince 2020-Q1 | Unchanged 0 |
TAYSHA GENE THERAPIES INC | 640,882 | $14.4M | 0.7% | $22.40 | 0.00% | 1 qtr | New 56 |
SPERO THERAPEUTICS INC | 1.1M | $12.4M | 0.6% | $10.60 | +5.28% | 5 qtrssince 2019-Q3 | Unchanged 0 |
IDEAYA BIOSCIENCES INC | 753,187 | $9.5M | 0.4% | $9.00 | +39.56% | 5 qtrssince 2019-Q3 | Unchanged 0 |
QUINCE THERAPEUTICS INC | 189,122 | $9.5M | 0.4% | $4,986.00 | +100.56% | 5 qtrssince 2019-Q3 | Unchanged 0 |
AUTOLUS THERAPEUTICS LTD | 698,262 | $8.1M | 0.4% | $12.42 | -6.28% | 5 qtrssince 2019-Q3 | Unchanged 0 |
| 900,718 | $7.4M | 0.3% | — | — | 5 qtrssince 2019-Q3 | Decreased 0 | |
Evelo Biosciences Inc | 1.1M | $5.6M | 0.3% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
FULCRUM THERAPEUTICS INC | 678,141 | $5.4M | 0.3% | $6.73 | +17.89% | 5 qtrssince 2019-Q3 | Decreased 0 |
Cloudera Inc | 427,710 | $4.7M | 0.2% | — | — | 5 qtrssince 2019-Q3 | Unchanged 0 |
CROWDSTRIKE HLDGS INC | 31,020 | $4.3M | 0.2% | $14.19 | +141.85% | 5 qtrssince 2019-Q3 | Unchanged 0 |
Alphabet Inc. manages $2.1B across 24 positions as of Q3 2020. Top holdings: JD (49.4%), LYFT (16.6%), DXCM (15.6%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added RLAY, LMND and TSHA; exited ONEM, SDGR and SNAP; trimmed 3, led by FULC (−4,099 shares). Top move: RLAY (NEW, conviction 83). Portfolio: $2.1B across 24 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR